Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma. - Gamboa-Cedeño AM; Díaz M; Cristaldo N; Otero V; Schutz N; Fantl D; Cugliari S; Zerga M; Rojas-Bilbao E; Jauk F; García Rivello H; Nuñez M; et al. (Life sciences, 2021)